An alkylate base oil of biological origin and a process to make an alkylate base oil comprising: a) hydrogenating a farnesene to make a farnesane comprising from zero to less than 5 wt % unsaturated molecules; and b) alkylating the farnesane with one or more C6 to C43 olefins in the presence of an acidic alkylation catalyst to make the alkylate base oil having a kinematic viscosity at 100° C. from 3 mm.sup.2/s to 20 mm.sup.2/s.

Improved alkylation catalysts, alkylation methods, and methods of making alkylation catalysts are described. The alkylation method comprises reaction over a solid acid, zeolite-based catalyst and can be conducted for relatively long periods at steady state conditions. The alkylation catalyst comprises a crystalline zeolite structure, a Si/Al molar ratio of 20 or less, less than 0.5 weight percent alkali metals, and further having a characteristic catalyst life property. Some catalysts may contain rare earth elements in the range of 10 to 35 wt %. One method of making a catalyst includes a calcination step following exchange of the rare earth element(s) conducted at a temperature of at least 575° C. to stabilize the resulting structure followed by an deammoniation treatment. An improved method of deammoniation uses low temperature oxidation.

Improved alkylation catalysts, alkylation methods, and methods of making alkylation catalysts are described. The alkylation method comprises reaction over a solid acid, zeolite-based catalyst and can be conducted for relatively long periods at steady state conditions. The alkylation catalyst comprises a crystalline zeolite structure, a Si/Al molar ratio of 20 or less, less than 0.5 weight percent alkali metals, and further having a characteristic catalyst life property. Some catalysts may contain rare earth elements in the range of 10 to 35 wt %. One method of making a catalyst includes a calcination step following exchange of the rare earth element(s) conducted at a temperature of at least 575° C. to stabilize the resulting structure followed by an deammoniation treatment. An improved method of deammoniation uses low temperature oxidation.

Methods are provided for forming aromatic compounds from a highly unsaturated aliphatic feeds optionally in combination with methanol. The method can include dehydrogenating a feed containing at least about 50 vol % C.sub.1-C.sub.4 alkanes under dehydrogenation conditions to form a dehydrogenation effluent containing at least about 25 vol % alkynes. Alternatively, other sources of alkyne-containing feeds can be used. At least a portion of the alkyne-containing feed can then be converted under effective conversion conditions to form a conversion effluent comprising a hydrocarbon product containing aromatic compounds.

Improved alkylation catalysts, alkylation methods, and methods of making alkylation catalysts are described. The alkylation method comprises reaction over a solid acid, zeolite-based catalyst and can be conducted for relatively long periods at steady state conditions. The alkylation catalyst comprises a crystalline zeolite structure, a Si/Al molar ratio of 20 or less, less than 0.5 weight percent alkali metals, and further having a characteristic catalyst life property. Some catalysts may contain rare earth elements in the range of 10 to 35 wt %. One method of making a catalyst includes a calcination step following exchange of the rare earth element(s) conducted at a temperature of at least 575° C. to stabilize the resulting structure followed by an deammoniation treatment. An improved method of deammoniation uses low temperature oxidation.

Improved alkylation catalysts, alkylation methods, and methods of making alkylation catalysts are described. The alkylation method comprises reaction over a solid acid, zeolite-based catalyst and can be conducted for relatively long periods at steady state conditions. The alkylation catalyst comprises a crystalline zeolite structure, a Si/Al molar ratio of 20 or less, less than 0.5 weight percent alkali metals, and further having a characteristic catalyst life property. Some catalysts may contain rare earth elements in the range of 10 to 35 wt %. One method of making a catalyst includes a calcination step following exchange of the rare earth element(s) conducted at a temperature of at least 575° C. to stabilize the resulting structure followed by an deammoniation treatment. An improved method of deammoniation uses low temperature oxidation.

A process and a device for continuous flow side-chain alkylation which relate to the technical field of organic synthesis. In this process and the device for continuous flow side-chain alkylation, an ibuprofen raw material is prepared with alkylbenzene as a raw material. This raw material alkylbenzene is easily available and has a low cost, and is suitable for scale-up production. Moreover, an entire preparation process adopts continuous chemical synthesis, and a reaction time of each stage can be precisely controlled, which is beneficial to control a total reaction time and reduce an amount of impurities produced. In this way, a purity and a yield of the ibuprofen raw material are improved. In summary, a continuous synthesis method for side-chain alkylation of alkylbenzene provided by the present disclosure shows a low cost and a high yield.

A process and a device for continuous flow side-chain alkylation which relate to the technical field of organic synthesis. In this process and the device for continuous flow side-chain alkylation, an ibuprofen raw material is prepared with alkylbenzene as a raw material. This raw material alkylbenzene is easily available and has a low cost, and is suitable for scale-up production. Moreover, an entire preparation process adopts continuous chemical synthesis, and a reaction time of each stage can be precisely controlled, which is beneficial to control a total reaction time and reduce an amount of impurities produced. In this way, a purity and a yield of the ibuprofen raw material are improved. In summary, a continuous synthesis method for side-chain alkylation of alkylbenzene provided by the present disclosure shows a low cost and a high yield.

The present invention relates to a molecular sieve, particularly to an ultra-macroporous molecular sieve. The present invention also relates to a process for the preparation of the molecular sieve and to its application as an adsorbent, a catalyst, or the like. The molecular sieve has a unique X-ray diffraction pattern and a unique crystal particle morphology. The molecular sieve can be produced by using a compound represented by the following formula (I), ##STR00001## wherein the definition of each group and value is the same as that provided in the specification, as an organic template. The molecular sieve is capable of adsorbing more/larger molecules, thereby exhibiting excellent adsorptive/catalytic properties.

The present invention relates to a molecular sieve, particularly to an ultra-macroporous molecular sieve. The present invention also relates to a process for the preparation of the molecular sieve and to its application as an adsorbent, a catalyst, or the like. The molecular sieve has a unique X-ray diffraction pattern and a unique crystal particle morphology. The molecular sieve can be produced by using a compound represented by the following formula (I), ##STR00001## wherein the definition of each group and value is the same as that provided in the specification, as an organic template. The molecular sieve is capable of adsorbing more/larger molecules, thereby exhibiting excellent adsorptive/catalytic properties.